Researchers awarded £1.5m for national dementia inequalities network
The ESRC EquaDem Network Plus aims to improve disparities in diagnosis and care
Read Moreby Jen Brogan | Jul 11, 2024 | News | 0
The ESRC EquaDem Network Plus aims to improve disparities in diagnosis and care
Read Moreby Jen Brogan | Jul 1, 2024 | News | 0
The biotech company will develop novel therapeutic drugs for the treatment of fatal diseases
Read Moreby Jen Brogan | May 22, 2024 | News | 0
Currently the third most common cancer in the UK, lung cancer affects 40,000 people annually
Read Moreby Jen Brogan | May 17, 2024 | News | 0
Areas include health research across life stages, from paediatrics to health ageing and resilience
Read Moreby Jen Brogan | Apr 8, 2024 | News | 0
The project aims to advance therapeutics for tuberculosis, malaria and hepatitis C in LMICs
Read Moreby Jen Brogan | Mar 28, 2024 | News | 0
Set to open in 2032, the RUEDI facility is funded by the UKRI’s recent infrastructure fund worth £388m
Read Moreby Jen Brogan | Dec 8, 2023 | News | 0
One-third of patients who received Pfizer’s COVID-19 vaccine had unintended immune responses
Read Moreby Jen Brogan | Oct 24, 2023 | News | 0
Malaria was responsible for over 600,000 worldwide deaths in 2021
Read Moreby Selina McKee | Jul 8, 2020 | News | 0
AGILE is a ‘proof of confidence engine’ designed to quickly identify the most promising compounds for treatment of COVID-19
Read Moreby Selina McKee | May 15, 2018 | News | 0
The Medicines Discovery Catapult, the Centre for Drug Safety Sciences at the University of Liverpool and the National Centre for the Replacement Refinement & Reduction of Animals in Research are working together to “propel” the UK into the race to advance organ on a chip technology.
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
